BiotechTubeBiotechTube
Home/Pipeline/ABBV-951

ABBV-951

Parkinson's disease

Phase 3Active

Key Facts

Indication
Parkinson's disease
Phase
Phase 3
Status
Active
Company
AbbVie

About AbbVie

AbbVie Inc. is a research-based biopharmaceutical company formed in 2013 as a spinoff from Abbott Laboratories. The company focuses on developing and delivering innovative therapies that address some of the world's most complex and serious diseases. With a strong portfolio led by immunology treatments and a growing oncology franchise, AbbVie has established itself as a leader in specialty therapeutics with global operations and a commitment to advancing patient care.

View full company profile

Therapeutic Areas

ImmunologyOncologyNeuroscienceEye CareVirology

Other Parkinson's disease Drugs

DrugCompanyPhase
UCB0107UCBPhase 1
StalevoOrion CorporationApproved
Comtan/ComtessOrion CorporationApproved
CHRONOS-PD PlatformGrifolsResearch
GT-001 (Gene Therapy)Sumitomo PharmaPhase 1/2
CREXONT (Carbidopa/Levodopa)Amneal PharmaceuticalsApproved
BIIB122/DNL151Denali TherapeuticsPhase 3
ABBV-0805BioArctic ABPhase 1
BAN1202BioArctic ABPreclinical
ARV-102ArvinasPhase 1
AAV-GADMeiraGTxPreclinical/Phase 1
Not SpecifiedMinerva NeurosciencesClinical Stage